SEARCH RESULT

Total Matching Records found : 1516

Lancet rejects 'commercial exploitation' of nutrition campaign -Trithesh Nandan

-Governance Now Magazine turns down red flag raised by a group of experts; says private food manufacturers part of campaign but "harmful" soft drink makers are not Days after a group of independent experts criticised the "commercial exploitation" of malnutrition and said the private sector should be kept out of any crusade against malnutrition, the Lancet, the renowned British medical journal, has advocated just the opposite, saying private players ought to...

More »

Ranbaxy drugs fine, say WHO and UK regulator -Rema Nagarajan

-The Times of India NEW DELHI: In yet another twist to the Ranbaxy scandal, the drug regulatory authority of the UK government has issued a statement clarifying that they have found no evidence of any Ranbaxy product in the UK market having been "of unacceptable quality". Last month, WHO had issued a similar statement. It had said that there was no evidence of any of the Ranbaxy products being of unacceptable...

More »

Ignore Lancet series, experts tell Centre -Rema Nagarajan

-The Times of India NEW DELHI: Several nutrition experts and members of the Indian Academy of Paediatrics, the largest association of paediatricians in India, have warned that the new set of papers on malnutrition published in the medical journal, Lancet, "should not be allowed to become an opportunity for commercial exploitation of malnutrition". "The call for engaging with the "private sector" and unregulated marketing of commercial foods for preventing malnutrition in children...

More »

Govt bans popular diabetes drug and analgin -Rupali Mukherjee

-The Times of India MUMBAI: The government has banned three popular medicines-the widely prescribed anti-diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit-in the wake of health risks associated with them. While it's believed that pioglitazone can cause heart failure and increases the risk of bladder cancer, analgin has been discarded the world over on grounds of patient safety. Deanxit, on the other hand is a harmful combination, which has been long...

More »

Planning Commission approves Rs 47000 crore plan size for Karnataka

-ANI Ahluwalia appreciated the State Government for strategy to make growth more inclusive and giving right priority to social sector The Planning Commission has approved an annual plan outlay of Rs 47,000 crore for Karnataka for the year 2013-14. The plan size was finalized in a meeting between Planning Commission Deputy Chairman Montek Singh Ahluwalia and Karnataka Chief Minister Siddaramaiah here last evening. The plan size has been agreed at Rs. 47,000 crore...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close